Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: Taiwan's TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan... Read more
Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to develop a series of... Read more
Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the US FDA under a special... Read more
Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and... Read more
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the... Read more
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption,... Read more
Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209 abstracts from... Read more
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds... Read more
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatment of genotype (GT1)... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
